Tuesday, November 4, 2025
  • Login
Euro Times
No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
Euro Times
No Result
View All Result

Stocks to Track: BEL, HAL, Polycab, Radico Khaitan, NTPC, other scrips in spotlight

by zee business
September 25, 2025
in Business
Reading Time: 3 mins read
A A
0
Home Business
Share on FacebookShare on Twitter


Home fairness benchmarks fell about half a share level every amid promoting stress in monetary, IT, and oil and fuel shares although shopping for curiosity in metallic scrips lent some assist. The Sensex gave up 386.5 factors to finish at 81,715.6 whereas the Nifty50 misplaced 112.6 factors to 25,056.9, persevering with to fall for the fourth buying and selling session in a row. As traders await the subsequent session on Dalal Road, listed below are a number of shares which can be set to be in focus in Thursday’s commerce:

Polycab block deal buzz

The corporate is about to bear a block deal to the tune of Rs 880 crore the place promoters are more likely to offload 12 lakh shares at Rs 7,300 low cost, marking a 3.1 per cent low cost to the market worth, in response to Zee Enterprise analysis.

Glenmark Pharma

Add Zee Enterprise as a Most well-liked Supply

The drug maker’s subsidiary, Glenmark Specialty SA, has signed an unique license and collaboration settlement with Hengrui Pharma for Trastuzumab Rezetecan (SHR-A1811), a most cancers therapy medication.

Defence PSU shares BEL and HAL

HAL and BEL have secured offers amounting to Rs 6,400 crore from the IAF, sources advised Zee Enterprise.

Lupin

The US drug regulator has grants tentative approval for generic Biktarvy tablets to Lupin. 

The Bictegravir, Emtricitabine and Tenofovir Alafenamide tablets are generics sed within the therapy of HIV. 

Gujarat Pipavav Port

The corporate has secured a five-year cope with ONGC for a port and storage facility hiring in Pipavav, Gujarat. 

Crisil

The score company’s board has approves the acquisition of 100 per cent in McKinsey PriceMetrix Co by way of step-down subsidiary Crisil Canada Inc.

The deal is estimated to be value Rs 335 crore. 

Waaree Energies

The corporate is about to take a position a sum of Rs 300 crore in subsidiary Waaree Vitality Storage Options by way of rights.  

Radico Khaitan and Piccadily Agro

Piccadily Agro has gained a lawsuit towards Radico Khaitan in a trademark violation-related matter.

Radico’s model title ‘KASHMYR’ was discovered to be much like Piccadily’s registered manufacturers ‘CASHMIR’ and ‘CASHMERE’. 

The interim order restricts Radico from manufacturing, promoting or promoting liquor beneath brandname ‘KASHMYR’ till ultimate judgment. 

ALSO READ: Swiggy eyes Rs 2,500 crore from Rapido stake sale—Must you purchase, promote or maintain?

Panacea Biotec

The corporate’s subsidiary, Panacea Biotec Pharma, has launched 100 per cent toxic-free merchandise for infants.

Birla Company

The corporate’s subsidiary, RCCPL, has been declared the popular bidder for a composite licence by the Telangana authorities. 

NTPC

The PSU’s subsidiary, THDC India, has introduced a COD of Unit II (660 MW) beneath the Khurja STPP (2X660 MW) undertaking, with operations set to start from September 26. 

The NTPC group’s complete put in and business capability has risen to 83,696 MW. 

Dalmia Bharat

The Enforcement Directorate has quickly connected land and different belongings amounting to Rs 793 crore linked to the corporate’s subsidiary, DCBL in a 2011 CBI case alleging irregularities in sure investments in Bharathi Cement. 

Motilal Oswal Monetary Providers

The brokerage’s subsidiary has acquired 10,95,890 CCPS and 16.43 lakh shares in Kusumgar for Rs 100 crore. 

Camlin Advantageous Sciences 

The corporate’s board is about to satisfy on September 29 to think about fairness share issuance by way of a non-public placement of shares for fundraising. 

A preferential share swap for the Vinpai acquisition can be into account. 

Cipla

The drug maker’s board is slated to satisfy on October 30 to evaluate its Q2 outcomes. 

Torrent Prescription drugs

The drug maker has points business papers to the tune of Rs 200 crore. 



Source link

Tags: BELHALKhaitanNTPCPolycabRadicoscripsspotlightstockstrack
Previous Post

Iran Infiltrates Israeli Secret Nuclear Research Facility

Next Post

‘End something that shouldn’t have started’: Donald Trump pledges to block Israel’s West Bank annexation; ceasefire still uncertain

Related Posts

Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call Transcript

Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call Transcript

by SA Transcripts
November 4, 2025
0

Operator Good afternoon, and welcome to Fortress Biosciences' Third Quarter 2025 Convention Name. As a reminder, at the moment's name...

Tesla Sued Over Claim Faulty Doors Led To Deaths In Fiery Crash

Tesla Sued Over Claim Faulty Doors Led To Deaths In Fiery Crash

by Bloomberg News
November 3, 2025
0

Tesla’s door handles have drawn elevated consideration after a Bloomberg Information investigation uncovered a sequence of incidents during which individuals had been...

Bharti Airtel to acquire 5% more in Indus Towers, deal worth over ₹5,000 crore

Bharti Airtel to acquire 5% more in Indus Towers, deal worth over ₹5,000 crore

by Euro Times
November 3, 2025
0

Bharti Airtel clarified that the acquisition is not going to be handled as a related-party transaction. Vodafone had totally exited...

Teva jumps ahead of Q3 results

Teva jumps ahead of Q3 results

by Shiri Habib-Valdhorn
November 4, 2025
0

The share value of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) rose 8.1% final week on Wall Road,...

The new great game over rare earths

The new great game over rare earths

by Euro Times
November 3, 2025
0

China’s choice on October 9 to increase export restrictions on seven Uncommon Earth Components (REEs) — very important for high-tech...

American Century Equity Income Fund Q3 2025 Commentary

American Century Equity Income Fund Q3 2025 Commentary

by American Century Investments
November 3, 2025
0

This text was written byComply withAmerican Century Investments is a number one asset supervisor centered on delivering funding outcomes and...

Next Post
‘End something that shouldn’t have started’: Donald Trump pledges to block Israel’s West Bank annexation; ceasefire still uncertain

‘End something that shouldn’t have started’: Donald Trump pledges to block Israel’s West Bank annexation; ceasefire still uncertain

4 Supplements To Avoid With Blood Pressure Medications

4 Supplements To Avoid With Blood Pressure Medications

NTT Inc. ADR (NTTYY) Q2 2026 Earnings Call Transcript

NTT Inc. ADR (NTTYY) Q2 2026 Earnings Call Transcript

November 4, 2025
Worker dies in Italy after rescue from partially collapsed medieval tower | News

Worker dies in Italy after rescue from partially collapsed medieval tower | News

November 4, 2025
Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call Transcript

Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call Transcript

November 4, 2025
Dream Impact Trust Q3 Loss Rises

Dream Impact Trust Q3 Loss Rises

November 4, 2025
Logitech is going after keyboard snobs with the hot-swappable Alto Keys K98M

Logitech is going after keyboard snobs with the hot-swappable Alto Keys K98M

November 4, 2025
The Jamaican Families Torn Apart by Hurricane Melissa

The Jamaican Families Torn Apart by Hurricane Melissa

November 4, 2025
Euro Times

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Finance
  • Health
  • Investing
  • Markets
  • Politics
  • Stock Market
  • Technology
  • Uncategorized
  • World

LATEST UPDATES

NTT Inc. ADR (NTTYY) Q2 2026 Earnings Call Transcript

Worker dies in Italy after rescue from partially collapsed medieval tower | News

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In